相关实验视频
Updated: May 5, 2026

Culturing and Manipulation of O9-1 Neural Crest Cells
Published on: October 9, 2018
河马通路的药理学调节剂:药物开发的进步和挑战
Zhaobai Lao1, Xin Chen1, Bin Pan1
1Department of Orthopedics Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
河马信号通路调节器官大小和组织修复. 针对这种途径的新药物,包括TEAD的药物,在治疗癌症和骨疾病等疾病方面表现有前途.
科学领域:
- 蜂信号传输是如何进行的
- 分子生物学分子生物学
- 发育生物学是发展生物学.
背景情况:
- 河马信号通路是器官大小,组织再生和骨平衡的关键调节者.
- 这种途径的调节失调,导致YAP/TAZ激活,与瘤进展和受损组织修复有关.
- 尽管它很重要,开发针对河马通路的向疗法一直是历史上具有挑战性的.
研究的目的:
- 为了回顾Hippo信号通路调节器的最新进展.
- 分析Hippo激动剂和对抗剂的机制,特性和体内应用.
- 突出针对Hippo路径及其下游效应器 (如TEAD) 的治疗潜力.
主要方法:
- 对Hippo通路调节器的临床前和临床研究的文献综述.
- 对针对YAP/TAZ和TEAD的药物发现工作的分析.
- 综合了有关调控机制和药理学概况的数据,对抗剂和激动剂.
主要成果:
- 在开发Hippo信号通路的激动剂和对抗剂方面取得了重大进展.
- 一些针对TEAD的药物,一个关键的下游效应因子,正在临床试验中,结果很有希望.
- 这些疗法显示出治疗癌症,促进组织再生和维持骨稳定性的潜力.
结论:
- 准河马信号通路代表了对各种疾病的有前途的治疗策略.
- 目前正在进行的TEAD抑制剂的研究和临床试验正在推动这一领域的发展.
- 对Hippo通路调节器的进一步研究可能会为器官大小控制和再生医学开启新的治疗方法.
更多相关视频
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
Drug Discovery: Overview
Drug Regulation
Preclinical Development: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...